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contains 149 modiﬁers (or noncoding variants) and 19 moderate (or
missense) and two low-impact (or synonymous) SNPs. Polyphen (5)
and Sorting Intolerant From Tolerant (6) prediction scores,
presented in the network table as attributes, were also consulted to
elucidate the deleteriousness of the 19 missense variants. The
Polyphen resulted in ﬁve probably damaging (rs141159367,
rs1051740, rs10499052, rs146043252, and rs28929474) and two
possibly damaging (rs1048943 and rs181206) SNPs. Sorting
Intolerant from Tolerant indicated that only three (rs1051740,
rs10499052, and rs146043252) of the seven SNPs identiﬁed by
Polyphen are predicted to be deleterious. Because of this
discrepancy, we considered the more extensive list. In Figure 1, a
SNP–gene–pathway subnetwork is presented, highlighting only the
connections related to the seven genes carrying the deleterious
missense SNPs.
The variant effect predictor analysis showed that the vast
majority of the SNPs associated with COPD are modiﬁers. Nineteen
of the 181 variants were missense SNPs mutations. Of these, seven
SNPs (rs10499052, rs28929474, rs181206, rs1048943, rs1051740,
rs141159367, and rs146043252) showed alterations predicted to
be deleterious in the associated proteins for SLC22A11 (solute
carrier family 22 member 11), AK9 (adenylate kinase 9), SERPINA1
(serpin family A member 1), IL27, CYP1A1 (cytochrome P450
family 1 subfamily A member), EPHX1 (epoxide hydrolase 1), and
TESMIN (testis-expressed metallothionein-like protein),
respectively. Figure 1 displays the interactions of those seven genes
with the missense SNPs and pathways. Interestingly, all but two of
the deleterious alterations, located in AK9 and TESMIN, are in
genes that are either directly or indirectly involved in inﬂammatory
pathways. The AK9 gene mutation is involved in cellular metabolic
processes and in extrapulmonary tissues (7), whereas TESMIN is
involved in heavy metal ion binding and sequestering.
IL27 and SERPINA1 encode proteins directly involved
in inﬂammation. The leucine to proline substitution caused by
rs181206 (IL27) was predicted to be possibly damaging by Polyphen,
indicating a strong change in protein structure. Proline is known to
have an exceptional conformational rigidity, often causing structural
changes. SERPINA1 mutations account for around 2% of all COPD
cases (8); however, the PiMZ variant associated with this gene was
only observed in crude estimates and disappeared after adjusting
for smoking (9). Two deleterious SNPs, rs1048943 and rs1051740,
associated with CYP1A1 and EPHX1, are involved in detoxiﬁcation
pathways and, under some circumstances, may be directly linked,
as in benzo(a)pyrene-metabolism (WikiPathways identiﬁer:
WP696). n
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Resistance Heterogeneity and Small Airway
Asthma Phenotype
To the Editor:
We read with interest the elegant modeling data of Foy and
colleagues (1), who reported a 40% narrowing of small airways was
associated with clinically relevant alterations in asthma control and
quality of life. Such effects were commensurate with observed
responses to biologics on the frequency-dependent heterogeneity of
the resistance component of respiratory impedance measured by
impulse oscillometry (IOS), where the mean pooled effect on
resistance at 5 Hz (R5)2 resistance at 20 Hz (R20) was 20.04
(95% conﬁdence interval [CI], 20.03 to 20.05) (kPa/L) $ s.
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To further put these changes into clinical context, we
previously measured IOS in response to propranolol-induced
bronchoconstriction in patients with asthma where there was a
0.05 (kPa/L) $ s increase in R52R20 corresponding to a 104.1% (95%
CI, 22.6 to 185.6%) change, along with a subsequent bronchodilator
response to salbutamol of 20.17 (kPa/L) $ s and 2115.6% (95% CI,
255.6% to 2175.7%), respectively (2). Moreover, in a health
informatics evaluation of 302 patients with asthma, there was a 45%
increased risk for worse control in relation to oral corticosteroid use,
and 47% in relation to inhaled albuterol use measured during a 2-year
period when comparing cohorts of patients with asthma, using a cutoff
value for R52R20 of less than or greater than 0.07 (kPa/L) $ s (3).
Hence, the small airway asthma phenotype reﬂected by
abnormal R52R20 is associated with poorer control. We believe
the ﬁndings of Foy and colleagues (1) are important in further
validating the use of IOS in determining effects of treatments on
small airways of patients with asthma. n
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Reply to Lipworth and Kuo
From the Author:
I thank Prof. Lipworth and Dr. Kuo for their comments on our
manuscript (1). Our attempt is the ﬁrst of its kind to link patient-based
computational models of the small airways with patient outcome
measures. In line with the comments made by Prof. Lipworth with
respect to resistance at 5 Hz (R5)2 resistance at 20 Hz (R20) and
asthma risk in cross-sectional studies, I and others recently reported the
results of the ATLANTIS (Assessment of Small Airways Involvement
in Asthma) study, a large multinational study evaluating the association
of small airway disease with adult asthma outcomes (2).
ATLANTIS clearly identiﬁed that the oscillometrymeasureR52R20
was one of the strongest predictors of both asthma control and prior
asthma exacerbations among all the potential small airway indices.
The combination of our ﬁndings (1) with the ATLANTIS study
results (2) should now enable investigators to test interventions that
target the small airways, with R52R20 as an outcome measure. n
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Not All Home-based Exercise Programs Are
Home-based Pulmonary Rehabilitation Programs
To the Editor:
I read with great interest the article by Bhatt and colleagues entitled,
“Video Telehealth Pulmonary Rehabilitation Intervention in
Chronic Obstructive Pulmonary Disease Reduces 30-Day
Readmissions” (1).
The authors delivered pulmonary rehabilitation (PR), using two-
way live videoconferencing on a smartphone to 80 patients after
hospitalization for a chronic obstructive pulmonary disease (COPD)
acute exacerbation (AE), and compared them with 160 matched
patients. They report 30-day readmission rates, either all-cause or for
COPD AE, in the patients who participated in video PR that are
approximately three times lower than in the comparison group.
This study highlights the question of whether issues of access
and adherence to conventional in-center PR can be safely addressed
by using technology to bring a program directly to patients in their
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